Stay updated with breaking news from Genscript Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The Neuroscience Antibodies and Assays Market share is expected to increase by USD 1837.68 million from 2022 to 2027, with an accelerated CAGR...
SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP. The Thai FDA has approved VAILL COVITRAP as a Class 4 medical device, making Thailand the first country to approve the manufact...
/PRNewswire/ -- The gene synthesis services market will be dominated by North America during the forecast period. The region will account for 38% of the...
/PRNewswire/ -- The gene synthesis services market will be dominated by North America during the forecast period. The region will account for 38% of the...
The Global Peptide Synthesis Market Size was USD 4.3 Billion in 2021 and is projected to reach USD 6.2 Billion by 2030, exhibiting a CAGR of 7.7% during...